By Andy Gillespie, PharmD, AVP, Clinical Strategy, SlateRx As 2025 comes to a close, it’s time to look back at the year and how new therapies, evolving regulatory pressures,...
Managing pharmacy benefits is no longer a simple “set it and forget it” task. With ultra-high-cost therapies in market, and new benefit solutions emerging rapidly, employers face mounting pressure...
Managing pharmacy benefits is no longer a simple “set it and forget it” task. With ultra-high-cost therapies in market, and new benefit solutions emerging rapidly, employers face mounting pressure...
